[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"article-CSN-221026121--":3,"related-articles-undefined-undefined-3b0c143a-1ddd-4edc-8eae-c9192ac88aac-true":15},{"id":4,"type":5,"title":6,"pubDate":7,"logoUrl":8,"anpFeedCategory":9,"organisationTitle":10,"thirdParty":11,"body":12,"orgId":13,"description":14},"CSN-221026121","PRESSRELEASE"," Insilica and ProtoQSAR Integrate ProtoPRED® into ToxIndex to Advance Chemical Safety Assessment","2026-10-22T16:02:25.000+02:00","https:\u002F\u002Fwww.persberichten.nl\u002Fimg\u002Fpr-newswire.png","Economie","PR Newswire",true,"\u003Cp> \nThe partnership brings more than 60 ProtoPRED® predictive models to the 150+ computational tools in ToxIndex, supporting faster, more transparent and efficient in silico assessments.\u003C\u002Fp>\u003Cp> ROCKVILLE, Md. and VALENCIA, Spain, Oct. 22, 2026 \u002FPRNewswire\u002F -- Insilica, Inc., developer of the ToxIndex chemical safety intelligence platform, and ProtoQSAR SL, a computational chemistry company specializing in predictive toxicology, today announced a technology integration and distribution agreement. The integration uses a containerized deployment of ProtoPRED®, enabling its predictive models to operate within the ToxIndex environment. For on-premises deployments, this approach is designed to support the protection of confidential chemical structures within customer-controlled infrastructure.\u003C\u002Fp>\u003Cp> \n    \n                \n                    \n                \n    \nAs regulatory authorities worldwide accelerate the adoption of New Approach Methodologies (NAMs), safety teams need fast, reliable, animal-free tools to evaluate chemical hazards.\u003C\u002Fp>\u003Cp> The suite delivers more than 60 predictive models across nine specialized ProtoPRED® modules built for major regulatory requirements:\u003C\u002Fp>\u003Cp> - ProtoICH: Pharmaceutical impurity testing (ICH M7)\u003C\u002Fp>\u003Cp> - ProtoREACH: International regulatory assessments (e.g., EU REACH and K-REACH)\u003C\u002Fp>\u003Cp> - ProtoADME: Drug absorption and metabolism profiling\u003C\u002Fp>\u003Cp> - ProtoPHYSCHEM: Chemical and physical property profiling\u003C\u002Fp>\u003Cp> - ProtoTOX: Organ and systemic toxicity predictions\u003C\u002Fp>\u003Cp> - ProtoECO: Ecotoxicity and environmental fate predictions\u003C\u002Fp>\u003Cp> - ProtoED: Endocrine disruption predictions\u003C\u002Fp>\u003Cp> - ProtoNANO: Nanomaterial safety modeling\u003C\u002Fp>\u003Cp> - GenoITS: Integrated genotoxicity assessment\u003C\u002Fp>\u003Cp> \"By embedding ProtoPRED® directly into ToxIndex, we let safety teams evaluate candidate chemicals in minutes, and on-premises customers keep proprietary structures behind their own firewall,\" said Tom Luechtefeld, PhD, Chief Executive Officer of Insilica, Inc.\u003C\u002Fp>\u003Cp> \"Partnering with Insilica expands our regulatory-proven models directly into an integrated AI workflow, giving teams the speed and confidence they need for critical filings,\" said Rafael Gozalbes, PhD, Chief Executive Officer of ProtoQSAR SL.\u003C\u002Fp>\u003Cp> ProtoPRED® is available now to ToxIndex enterprise customers through an annual company-wide license with unlimited predictions and no per-user or per-query fees.\u003C\u002Fp>\u003Cp> About Insilica, Inc.\u003C\u002Fp>\u003Cp> Insilica, Inc. (Rockville, MD) develops computational toxicology and safety assessment software. Its flagship platform, ToxIndex, organizes chemical hazard data and biokinetic models into verifiable, animal-free risk assessments.\u003C\u002Fp>\u003Cp> About ProtoQSAR SL\u003C\u002Fp>\u003Cp> ProtoQSAR SL (Valencia, Spain), with over 15 years of experience developing proprietary (Q)SAR models, specializes in chemoinformatics, predictive modeling, and artificial intelligence for chemical safety applications across pharmaceuticals, cosmetics, and agrochemicals.\u003C\u002Fp>\u003Cp> \u003C\u002Fp>\u003Cp>                 \n                    \n\u003C\u002Fp>\u003Cp> \u003C\u002Fp>\u003Cp> \n View original content to download multimedia:https:\u002F\u002Fwww.prnewswire.co.uk\u002Fnews-releases\u002Finsilica-and-protoqsar-integrate-protopred-into-toxindex-to-advance-chemical-safety-assessment-302917030.html\u003C\u002Fp>","3b0c143a-1ddd-4edc-8eae-c9192ac88aac","The partnership brings more than 60 ProtoPRED® predictive models to the 150+ computational tools in ToxIndex, supporting faster, more transparent and efficient ",[16,21,26,31,36,37,42,47,52,57],{"id":17,"title":18,"pubDate":19,"logoUrl":8,"thirdParty":11,"orgId":13,"description":20},"CSN-221026155"," Prophix® ontsluit waarde voor klanten met nieuwe agentmogelijkheden en beveiligde toegang tot AI-ecosystemen","2026-10-22T19:57:26.000+02:00","Nieuwe AI-innovaties geven financiële teams het vertrouwen om complexere taken te delegeren, ondersteund door een platform dat is ontworpen voor nauwkeurigheid ",{"id":22,"title":23,"pubDate":24,"logoUrl":8,"thirdParty":11,"orgId":13,"description":25},"CSN-221026134"," Shamshi Kaldayakov's Songs Performed in Spanish in Madrid for the First Time, with Support of the Bulat Utemuratov Foundation","2026-10-22T17:10:25.000+02:00","MADRID, Oct. 22, 2026 \u002FPRNewswire\u002F -- On 21 October, the Auditorio Nacional de Música in Madrid hosted Shamshi Alemi, a concert celebrating renowned Kazakh comp",{"id":27,"title":28,"pubDate":29,"logoUrl":8,"thirdParty":11,"orgId":13,"description":30},"CSN-221026127"," Urgent notice from Narodowy Bank Polski: NBP cannot operate without its Governor","2026-10-22T16:40:25.000+02:00","WARSAW, Poland, Oct. 22, 2026 \u002FPRNewswire\u002F -- In view of the confusing information currently in circulation, we would like to restate the official position of N",{"id":32,"title":33,"pubDate":34,"logoUrl":8,"thirdParty":11,"orgId":13,"description":35},"CSN-221026122"," Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agen","2026-10-22T16:04:25.000+02:00","- GIM-621 is a preclinical-stage, first-in-class oral small molecule immunotherapy with potential application across multiple solid tumors. - Georgiamune to rec",{"id":4,"title":6,"pubDate":7,"logoUrl":8,"thirdParty":11,"orgId":13,"description":14},{"id":38,"title":39,"pubDate":40,"logoUrl":8,"thirdParty":11,"orgId":13,"description":41},"CSN-221026115"," ZwitterCo Announces Strategic Investment from Ecolab to Drive Water Circularity","2026-10-22T15:21:24.000+02:00","Investment enables companies to collaborate on advanced water reuse and circularity solutions for food and beverage manufacturers. WOBURN, Mass., Oct. 22, 2026 ",{"id":43,"title":44,"pubDate":45,"logoUrl":8,"thirdParty":11,"orgId":13,"description":46},"CSN-221026113"," ELEGOO Brings Professional-Grade 3D Scanning to a Wider Range of Creators with the Upcoming M1 Ultra","2026-10-22T15:17:24.000+02:00","SHENZHEN, China, Oct. 22, 2026 \u002FPRNewswire\u002F -- ELEGOO, a rapidly developing brand in global smart manufacturing, is expanding its 3D creation ecosystem with the",{"id":48,"title":49,"pubDate":50,"logoUrl":8,"thirdParty":11,"orgId":13,"description":51},"CSN-221026109"," Raytron Industrial Launches TN660 and TN463 Thermal Cameras for Dynamic Testing and Continuous Condition Monitoring","2026-10-22T15:05:25.000+02:00","YANTAI, China, Oct. 22, 2026 \u002FPRNewswire\u002F -- Raytron Industrial today announced the launch of two new products: the TN660 High Frame Rate Fixed-Mount Thermal Ca",{"id":53,"title":54,"pubDate":55,"logoUrl":8,"thirdParty":11,"orgId":13,"description":56},"CSN-221026108"," 77% of Enterprises Have Paid a Price for Ungoverned AI Agents","2026-10-22T15:02:24.000+02:00","New research from Redwood Software finds agentic AI is scaling faster than the integration, ownership and governance necessary to run it with confidence. VIENNA",{"id":58,"title":59,"pubDate":60,"logoUrl":8,"thirdParty":11,"orgId":13,"description":61},"CSN-221026096"," TFS HealthScience Unveils New Global Brand Identity","2026-10-22T14:06:26.000+02:00","New identity makes clear how Swedish-founded CRO works with biotech, pharma and medtech sponsors: radical honesty, scientific urgency, therapeutic depth and tea"]